Amarin Corp Plcuk (AMRN) Tax Provisions (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Tax Provisions of -$219000.0 for Q2 2026, down 131.79% year-over-year from $689000.0 in Q2 2025, and down 112.24% quarter-over-quarter from $1.8 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Tax Provisions (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Tax Provisions for 14 consecutive years, with -$219000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Provisions fell 131.79% year-over-year to -$219000.0; the TTM figure through Jun 2026 stood at -$10.2 million (up 46.92% YoY), while the FY2025 annual figure was -$9.0 million, up 53.31% from the prior year.
- Tax Provisions eased to -$219000.0 in Q2 2026 per AMRN's latest filing, from $1.8 million in the prior quarter.
- Across five years, Tax Provisions topped out at $5.2 million in Q2 2022 and bottomed at -$35.6 million in Q4 2022.
- Historically, Tax Provisions has averaged -$3.7 million across 5 years, with a median of $973000.0 in 2022.
- Annual changes were most pronounced in 2022 — Tax Provisions sank 247.49% — and 2024, when it surged 619.56%.
- Amarin Corp Plc\Uk's Tax Provisions stood at -$35.6 million in 2022, then surged by 56.36% to -$15.5 million in 2023, then slumped by 64.68% to -$25.6 million in 2024, then jumped by 55.46% to -$11.4 million in 2025, then soared by 98.08% to -$219000.0 in 2026.
- Business Quant data shows AMRN's Tax Provisions at -$219000.0 in Q2 2026, $1.8 million in Q1 2026, and -$11.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.01 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 291.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 266.99 Mn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | -219,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -219,000.00 |
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | -11.39 Mn |
| Sep 30, 2025 | -377,000.00 |
| Jun 30, 2025 | 689,000.00 |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | -25.57 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | -15.53 Mn |
| Sep 30, 2023 | 501,000.00 |
| Jun 30, 2023 | -355,000.00 |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | -35.58 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 5.16 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | -10.24 Mn |
| Sep 30, 2021 | 184,000.00 |